Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Objective Glucagon-like peptide-1 (GLP-1) has been investigated in regulation of reproductive system in animal models. The potential impact of short-term preconception intervention with liraglutide on fertility potential in polycystic ovary syndrome (PCOS) has not been evaluated yet. Design A prospective randomized open-label study was conducted in 28 infertile obese PCOS patients (age: 31.07 ± 4.75, BMI: 36.7 ± 3.5 kg/m 2 , mean ± s.d. ). They were assigned to metformin (MET) 1000 mg BID or to MET 1000 mg BID combined with low-dose liraglutide 1.2 mg QD s.c. (COMBI) for 12 weeks. Ovarian stimulation protocol was started after a 4-week medication-free period. Methods The in vitro fertilization pregnancy rate (PR) was defined as the number of clinical pregnancies confirmed by ultrasound visualization of the fetal cardiac activity, divided by the total number of cycles performed or embryo transfers (ET). The spontaneous PR was followed for 12 months. Results Patients in the MET group on average lost 7.0 ± 6.0 kg ( P = 0.001) compared with 7.5 ± 3.9 kg in the COMBI group ( P < 0.001) with no significant between-treatment difference ( P = 0.246). The PR per ET was significantly higher in the COMBI (85.7%) compared with the MET (28.6%) group ( P = 0.03). The cumulative PR in the time frame of 12 months was 69.2% in the COMBI group compared to 35.7% in the MET group. Conclusions Preconception intervention with low-dose liraglutide added to metformin is superior to metformin alone in increasing PRs per ET and cumulative PRs in infertile obese women with PCOS, despite comparable weight reduction in both groups. A potential impact of liraglutide on the reproductive system needs further exploration, in particular the GLP-1 impact on endometrial quality and receptivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“preconception administration of liraglutide 1.2 mg and metformin was associated with increased pregnancy rate per embryo transfer and cumulative pregnancy rate in women with obesity in PCOS compared to metformin monotherapy, despite similar weight reduction98.”
From Incretin-based therapies for the treatment of obesity-related diseases (2024) · cites this paper as [98]
In the citing paper
“Salamun et al. investigated infertile PCOS patients with obesity randomly assigned to metformin 1000 mg BID or to metformin 1000 mg BID combined with low-dose liraglutide 1.2 mg/day for 12 week, and demonstrated that weight, BMI, and WC decreased with both treatments, without significant difference between the two arms [59].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [59]
In the citing paper
“Salamun et al. observed that weight loss and significant increases in SHBG occurred in both groups [59].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [59]
In the citing paper
“the area of VAT was reduced in all the three treatments arms without inter-groups differences [59, 60].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [59]
In the citing paper
“Results have shown that double therapy was superior to metformin alone in increasing spontaneous pregnancies and in vitro fertilization pregnancy rates, wherein both treatment strategies resulted in comparable reduction in body weight and adipose tissue.”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [110]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer
Gardner, D. K., Lane, M., Stevens, J., Schlenker, T., & Schoolcraft, W. B. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00518-5 · Cited by 2,091
Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews
Marchi, J., Berg, M., Dencker, A., Olander, E. K., & Begley, C. (2015) · Obesity Reviews · doi:10.1111/obr.12288 · Cited by 991
Yildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I., & Yarali, H. (2012) · Human Reproduction · doi:10.1093/humrep/des232 · Cited by 704
Bethel, M. A., Patel, R. A., Merrill, P., Lokhnygina, Y., Buse, J. B., Mentz, R. J., Pagidipati, N. J., Chan, J. C., Gustavson, S. M., Iqbal, N., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30412-6 · Cited by 599
Leptin's Actions on the Reproductive Axis: Perspectives and Mechanisms
Cunningham, M. J., Clifton, D. K., & Steiner, R. A. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.2.216 · Cited by 532
Central Control of Body Weight and Appetite
Woods, S. C., & D'Alessio, D. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1630 · Cited by 458
Impact of Obesity on the Risk for Polycystic Ovary Syndrome
Yildiz, B. O., Knochenhauer, E. S., & Azziz, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1834 · Cited by 401
Randomized trial of a lifestyle program in obese infertile women
Mutsaerts, M. A. Q., van Oers, A. M., Groen, H., Burggraaff, J. M., Kuchenbecker, W. K. H., Perquin, D. A. M., Koks, C. A. M., van Golde, R., Kaaijk, E. M., Schierbeek, J. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505297 · Cited by 308
Research works printed but not linked: 50
- 2014, Physical activity before IVF and ICSI cycles in infertile obese women: an observational cohort study, Reproductive BioMedicine Online, 29, 72, 10.1016/j.rbmo.2014.03.006 · DOI · Paper page
- 2017, Effect of a lifestyle intervention in obese infertile women on cardiometabolic health and quality of life: results of a randomised controlled trial
- 2000, Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling, Endocrinology, 2, 752
- 2005, Glucagon-like peptide-1 reduces the pulsatile component of testosterone secretion in healthy males, European Journal of Clinical Investigation, 35, 565, 10.1111/j.1365-2362.2005.01542.x · DOI · Paper page
- 2014, Weight loss improves reproductive outcomes for obese women undergoing assisted reproductive technology: a randomised controlled trial, Clinical Obesity, 14, 792
- 1999, Leptin’s actions on the reproductive axis: perspectives and mechanisms, Biology of Reproduction, 60, 616
- 2009, Clinical review: the extrapancreatic effects of glucagon-like peptide-1 and related peptides, Journal of Clinical Endocrinology and Metabolism, 94, 1843, 10.1210/jc.2008-1296 · DOI · Paper page
- 2012, Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria, Human Reproduction, 27, 3067, 10.1093/humrep/des232 · DOI · Paper page
- PCOS, Special Interest Group The polycystic ovary syndrome : a position statement from the European of of https org, Society Endocrinology European Journal Endocrinology, 1
- 2018, Effect of liraglutide on ectopic fat in polycystic ovary syndrome: a randomized clinical trial, Diabetes, Obesity and Metabolism, 20, 215, 10.1111/dom.13053 · DOI · Paper page
- 1985, Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/bf00280883 · DOI · Paper page
- 2017, Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential, Endocrine Connections, 6, 89, 10.1530/ec-16-0113 · DOI · Paper page
- 2015, Normal pregnancy outcome after first-trimester exposure to liraglutide in a woman with Type 2 diabetes, Diabetic Medicine, 32, 29, 10.1111/dme.12726 · DOI · Paper page
- 2017, Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight/obese polycystic ovary syndrome, Clinical Endocrinology, 87, 767, 10.1111/cen.13454 · DOI · Paper page
- 2014, Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin, European Journal of Endocrinology, 170, 451, 10.1530/eje-13-0797 · DOI · Paper page
- 2003, Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women, Diabetes Care, 26, 1413, 10.2337/diacare.26.5.1413 · DOI · Paper page
- 1998, Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line, Journal of Clinical Investigation, 101, 1334, 10.1172/jci610 · DOI · Paper page
- 2008, Central control of body weight and appetite, Journal of Clinical Endocrinology and Metabolism, 93, 37, 10.1210/jc.2008-1630 · DOI · Paper page
- 2015, Exenatide improves ovarian and endometrial injury and preserves ovarian reserve in streptozocin induced diabetic rats, Gynecological Endocrinology, 31, 196, 10.3109/09513590.2014.975686 · DOI · Paper page
- 2008, Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome, Journal of Clinical Endocrinology and Metabolism, 93, 2670, 10.1210/jc.2008-0115 · DOI · Paper page
- 2017, Impact of body mass index on outcomes of in vitro fertilization/intracytoplasmic sperm injection among polycystic ovarian syndrome patient, Journal of Assisted Reproduction and Genetics, 34, 61
- 2015, Risks associated with obesity in pregnancy for the mother and baby: a systematic review of reviews, Obesity Reviews, 16, 621, 10.1111/obr.12288 · DOI · Paper page
- PCOS, Special Interest Group The polycystic ovary syndrome : a position statement from the European of of https org, Society Endocrinology European Journal Endocrinology, 1
- 2005, A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance, Diabetes Care, 28, 451, 10.2337/diacare.28.2.451 · DOI · Paper page
- 2018, Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis, Lancet Diabetes and Endocrinology, 6, 105, 10.1016/s2213-8587(17)30412-6 · DOI · Paper page
- 2005, Diabetes (db/db) mutation-induced endometrial epithelial lipoapoptosis: ultrastructural and cytochemical analysis of reproductive tract atrophy, Reproductive Biology and Endocrinology, 3, 15, 10.1186/1477-7827-3-15 · DOI · Paper page
- 2007, The management of insulin resistance in polycystic ovary syndrome, Trends in Endocrinology and Metabolism, 18, 273, 10.1016/j.tem.2007.08.001 · DOI · Paper page
- 2008, Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study, Human Reproduction, 23, 642, 10.1093/humrep/dem391 · DOI · Paper page
- 2007, Impact of obesity on the risk for polycystic ovary syndrome, Journal of Clinical Endocrinology and Metabolism, 93, 162
- 2014, Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome, Cochrane Database of Systematic Reviews, 11, CD006105
- 2017, Weight decrease improves live birth rates in obese women undergoing IVF: a pilot study, Reproductive BioMedicine Online, 35, 417, 10.1016/j.rbmo.2017.06.019 · DOI
- 2016, Successful pregnancy after improving insulin resistance with the glucagon-like peptide-1 analogue in a woman with polycystic ovary syndrome: a case report and review of the literature, Gynecologic and Obstetric Investigation, 81, 477, 10.1159/000446951 · DOI
- 2015, GLP-1 increases pre-ovulatory LH source and the number of mature follicles as well as synchronizing the onset of puberty in female rats, Endocrinology, 156, 4226, 10.1210/en.2014-1978 · DOI · Paper page
- 2014, Weight loss improves reproductive outcomes for obese women undergoing assisted reproductive technology: a randomised controlled trial, Clinical Obesity, 14, 792
- 2014, Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review, Obesity Reviews, 15, 839, 10.1111/obr.12217 · DOI · Paper page
- 2013, Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials, Reproductive BioMedicine Online, 120, 267
- 2017, Effect of a lifestyle intervention in obese infertile women on cardiometabolic health and quality of life: results of a randomised controlled trial
- 2011, Diet and IVF pilot study: short-term weight loss improves pregnancy rates in overweight/obese women undertaking IVF, Australian and New Zealand Journal of Obstetrics and Gynaecology, 51, 455, 10.1111/j.1479-828x.2011.01343.x · DOI · Paper page
- 2000, Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer, Fertility and Sterility, 73, 1155, 10.1016/s0015-0282(00)00518-5 · DOI · Paper page
- 2015, GLP-1 increases pre-ovulatory LH source and the number of mature follicles, as well as synchronizing the onset of puberty in female rats, Endocrinology, 156, 4226, 10.1210/en.2014-1978 · DOI · Paper page
- 2009, Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis, Human Reproduction Update, 15, 57
- 1999, Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone, Journal of Clinical Endocrinology and Metabolism, 84, 1470
- 2007, Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome, Clinical endocrinology, 66, 513, 10.1111/j.1365-2265.2007.02764.x · DOI · Paper page
- 2003, Successful freezing and thawing of blastocysts cultured in sequential media using a modified method, Fertility and Sterility, 79, 1428, 10.1016/s0015-0282(03)00395-9 · DOI
- 2015, GLP-1 increases pre-ovulatory LH source and the number of mature follicles as well as synchronizing the onset of puberty in female rats, Endocrinology, 156, 4226, 10.1210/en.2014-1978 · DOI · Paper page
- 2016, Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: randomized control study, Experimental and Therapeutic Medicine, 11, 1194, 10.3892/etm.2016.3081 · DOI · Paper page
- 2016, Randomized trial of a lifestyle program in obese infertile women, New England Journal of Medicine, 374, 1942, 10.1056/nejmoa1505297 · DOI · Paper page
- 2017, Adverse effects of female obesity and interaction with race on reproductive potential, Fertility and Sterility, 107, 868, 10.1016/j.fertnstert.2017.02.114 · DOI · Paper page
- 2017, Metformin therapy for the management of infertility in women with polycystic ovary syndrome, British Journal of Obstetrics and Gynaecology: An International Journal of Obstetrics and Gynaecology, 124, 306, 10.1111/1471-0528.14764 · DOI
- 2011, The effect of increasing obesity on the response to and outcome of assisted reproductive technology: a national study. Society for Assisted Reproductive Technology writing group, Fertility and Sterility, 96, 820, 10.1016/j.fertnstert.2011.07.1100 · DOI
Cited by
Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Glueck, C. J., & Goldenberg, N. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.002 · Cited by 442
Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408
“GLP-1RAs Liraglutide [164, 165] ↑ glucose-dependent insulin secretion↑ lipolysis nausea, vomiting patients with a personal or family history of MTC”
BackgroundEfficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
Drucker, D. J. (2024) · Diabetes Care · doi:10.2337/dci24-0003 · Cited by 383
Endometrial function in women with polycystic ovary syndrome: a comprehensive review
Palomba, S., Piltonen, T. T., & Giudice, L. C. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa051 · Cited by 372
Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists
Cena, H., Chiovato, L., & Nappi, R. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa285 · Cited by 356
“2 mg daily) in combination with metformin was superior to metformin alone in increasing in vitro fertilization pregnancy rates (97).”
Background
Metadata
- Authors
- Salamun, V., Jensterle, M., Janez, A., & Vrtacnik Bokal, E.
- Affiliations
- 1Division of Obstetrics and Gynecology, Department of Human Reproduction
- Ljubljana University Medical Centre (SI)
- 2Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia
- ORCID
- Jensterle, Mojca
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-07
- Volume
- 179
- Issue
- 1
- Pages
- 1-11
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2799507126
- Cited by
- 204
- References
- 46
- Citations by year
- 2026: 41 · 2025: 47 · 2024: 35 · 2023: 23 · 2022: 24 · 2021: 17 · 2020: 9 · 2019: 7 · 2018: 1
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- liraglutide, polycystic ovary syndrome, obesity, metformin, poor ovarian response, preconception interventions, GLP-1 receptor agonists, weight loss, infertility, endometrial receptivity
- MeSH terms
- Liraglutide, Adult, Drug Therapy, Combination, Female, Fertilization in Vitro, Humans, Hypoglycemic Agents, Infertility, Female, Metformin, Obesity, Ovulation Induction, Pilot Projects, Polycystic Ovary Syndrome, Pregnancy, Treatment Outcome, Pregnancy Rate, Sperm Injections, Intracytoplasmic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. https://app.cochat.ai/papers/10.1530/eje-18-0175
- The paper
- Salamun, V., Jensterle, M., Janez, A., & Vrtacnik Bokal, E. (2018). Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. European Journal of Endocrinology. https://doi.org/10.1530/eje-18-0175
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.